Latest Financials News

Australian Strategic Materials reports a significant 75% jump in NdFeB alloy deliveries at its Korean Metals Plant and advances heavy rare earth production, while announcing a transformative acquisition offer from Energy Fuels Inc.

Carnaby Resources has reported a 10% increase in its Greater Duchess Copper Gold Project resource, completed full ownership of the JV, and is advancing its pre-feasibility study with strong cash backing and promising drill results.

Nine Entertainment Co. is reshaping its media portfolio with the acquisition of QMS Media, the sale of its radio assets, and a regional TV affiliate deal, aiming to boost digital revenue to over 60% by FY27.

Nexus Minerals Limited reports significant progress at its Wallbrook Gold Project with high-grade drill results across multiple prospects and advancing permitting for Crusader-Templar. The company is positioning Wallbrook as an emerging gold camp with promising growth potential.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

Enlitic, Inc. reported its strongest quarter yet with record contract wins totalling A$4.3 million, alongside a strategic capital raise and new cost-saving measures to fuel growth.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

RMA Global Limited has rebranded RateMyAgent to Renowned, integrating Curated Social to enhance its real estate marketing platform. The company’s strategic pivot in the US is paying off with record brokerage deals and strong revenue growth.

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

Lotus Resources reports steady progress at its Kayelekera uranium mine despite supply challenges, while its Letlhakane project shows promising metallurgical advances. The company targets full production and first shipments in the second quarter of 2026.

FAR Limited’s December quarter report highlights robust production from the Sangomar field operated by Woodside Energy, alongside a strategic settlement of a $6 million claim with Woodside. The company ends the quarter with a modest cash balance, positioning itself cautiously for the near term.